SAFETY AND TOLERABILITY OF ODM-201 IN PATIENTS WITH PROSTATE CANCER: EXTENSION STUDY TO STUDY 3104001

Update Il y a 4 ans
Reference: EUCTR2010-022803-24

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this extension study is to gain more information about the long-term safety and tolerability of ODM-201.


Inclusion criteria

  • Progressive castration resistant prostate cancer (MedDRA: hormone-refractory prostate cancer)